James Shaw

James Shaw

Auto-generated profile, based on publicly available information

James Shaw

University of Toronto

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 July 2019 in Journal of Medical Internet Research
Verified
Journal Article
Open access
JSJames Shaw
James Shaw
FRFrank Rudzicz
Frank Rudzicz
TJTrevor Jamieson
Trevor Jamieson
AGAvi Goldfarb
Avi Goldfarb
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Applications of artificial intelligence (AI) in health care have garnered much attention in recent years, but the implementation issues posed by AI have not been substantially addressed. Objective: In this paper, we focus on Machine Learning (ML) as a form of AI, and provide a framework for thinking about use cases of ML in health care. We structure our discussion of challenges in the implementation of ML in comparison to other technologies using the Framework of Nonadoption, Abandonment, and Challenges to the Scale-up Spread and Sustainability of Health and Care Technologies (NASSS). Methods: After providing an overview of AI technology, we describe use cases of ML as falling into the categories of decision support and automation. We suggest these use cases apply to clinical, operational, and epidemiological tasks, and that the primary function of ML in health care in the near term will be decision support. We then outline unique implementation issues posed by ML initiatives in the categories addressed by the NASSS framework, specifically including meaningful decision support, explainability, privacy, consent, algorithmic bias, security, scalability, the role of corporations, and the changing nature of health care work. Results: Ultimately, we suggest that the future of ML in health care remains positive but uncertain, as support from patients, the public, and a wide range of health care stakeholders is necessary to enable its meaningful implementation. Conclusions: If the implementation science community is to facilitate the adoption of ML in ways that stand to generate widespread benefits, the issues raised in this paper will require substantial attention in the coming years.

10 January 2019 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
PAPayal Agarwal
Payal Agarwal
GMGeetha Mukerji
Geetha Mukerji
LDLaura Desveaux
Laura Desveaux
NINoah M Ivers
Noah M Ivers
OBOnil Bhattacharyya
Onil Bhattacharyya
RBR Sacha Bhatia
R Sacha Bhatia
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: As the increasing prevalence of Type 2 Diabetes (T2DM) has put pressure on health systems to appropriately manage these patients, there have been a growing number of mobile apps designed to improve the self-management of diabetes. One such app, called BlueStar, has been shown to significantly reduce HbA1c in small studies and is the first app in the USA to receive FDA approval as a Mobile Prescription Therapy. However, the impact of the app across “real world” population among different clinical sites and health systems remains unclear. Objective: The primary objective of this study was to conduct a pragmatic randomized control trial of the BlueStar mobile app to determine if app usage leads to improved HbA1c levels among diverse participants in real-life clinical contexts. We hypothesized that this mobile app would improve self-management and improve HbA1c levels compared to controls. Methods: The study consisted of a multi-center pragmatic randomized control trial. 110 participants randomized to the Immediate Treatment Group (ITG) received the intervention for 6 months and 113 randomized to the Wait-list Control group (WLC) received usual care for the first three months and then received the intervention for 3 months. The primary outcome was glucose control measured by HbA1c at 3 months. Secondary outcomes assessed intervention impact on patient self-management, experience of care and self-reported health utilization using validated scales including the Problem Areas in Diabetes (PAID), the Summary of Diabetes Self-Care Activities (SDSCA) and the EQ-5D. Intervention usage was collected directly from the app. Results: The results of an ANCOVA controlling for baseline HbA1c did not show evidence of intervention impact on HbA1c at 3 months (mean difference (ITG-WLC) -0.42, 95% confidence interval [CI] -1.05 to 0.21; p=0.19). Similarly, there was no intervention effect on secondary outcomes measuring diabetes self-efficacy, quality of life and health care utilization behaviours. An exploratory analysis of 57 ITG participants investigating the impact of app usage on HbA1c levels showed that each additional day of app use corresponded with a 0.016-point decrease in participant’s 3-month (95% CI -0.03 to -0.003)). App usage varied significantly by site, as participants from one site logged in to the app a median of 36 days over 14 week (interquartile range [IQR] 10.5 to 124), those at another site used the app significantly less (median 9, IQR 6 to 51). Conclusions: The results showed no difference between intervention and control arms for the primary clinical outcome of glycemic control as measured by HbA1c. While there was low usage of the app among participants, results indicate that contextual factors, particularly site, had a significant impact on overall usage. Future research into the patient and site-specific factors that increase app utilization is needed. Clinical Trial: Clinicaltrials.gov NCT02813343. Registered on 24 June 2016 (retrospectively registered).

20 September 2018 in npj Digital Medicine
Verified
Journal Article
Open access
PDF file
JSJames Shaw
James Shaw
PAPayal Agarwal
Payal Agarwal
LDLaura Desveaux
Laura Desveaux
DPDaniel Cornejo Palma
Daniel Cornejo Palma
VSVess Stamenova
Vess Stamenova
OBOnil Bhattacharyya
Onil Bhattacharyya
Digital tools have shown great potential to enhance health services’ capacity to achieve the goals of the triple aim (enhance patient experience, improve health outcomes, and control or reduce costs), but their actual impact remains variable. In this commentary, we suggest that shifting from a perspective focused on “implementing” new digital tools in health care settings toward one focused on “service design” will help teams execute more successful digital technology adoption projects. We present value proposition design (VPD) as a service design strategy requiring that stakeholders are brutally honest in determining the value of a new digital tool for their everyday work. Incorporating a perspective focused on how the value proposition of a technology is understood by each team member, and implications for their work routines, will help project teams to better understand how services can be reinvented during technology adoption initiatives. We present the simple heuristic [Tool+Team+Routine] as a reminder of the central considerations that make up a service design initiative, and present an illustrative case scenario of designing the use of a digital care coordination platform in an actual digital technology adoption project. We conclude by outlining two important challenges that need to be addressed to advance service design approaches to technology adoption in health care.

24 September 2017 in Journal of Telemedicine and Telecare
Verified
Journal Article
Closed access
JSJames Shaw
James Shaw
TJTrevor Jamieson
Trevor Jamieson
PAPayal Agarwal
Payal Agarwal
BGBailey Griffin
Bailey Griffin
IWIvy Wong
Ivy Wong
RBR. Sacha Bhatia
R. Sacha Bhatia
Background: The development of new virtual care technologies (including telehealth and telemedicine) is growing rapidly, leading to a number of challenges related to health policy and planning for health systems around the world. Methods: We brought together a diverse group of health system stakeholders, including patient representatives, to engage in policy dialogue to set health system priorities for the application of virtual care in the primary care sector in the Province of Ontario, Canada. We applied a nominal group technique (NGT) process to determine key priorities, and synthesized these priorities with group discussion to develop recommendations for virtual care policy. Methods included a structured priority ranking process, open-ended note-taking, and thematic analysis to identify priorities. Results: Recommendations were summarized under the following themes: (a) identify clear health system leadership to embed virtual care strategies into all aspects of primary and community care; (b) make patients the focal point of health system decision-making; (c) leverage incentives to achieve meaningful health system improvements; and (d) building virtual care into streamlined workflows. Two key implications of our policy dialogue are especially relevant for an international audience. First, shifting the dialogue away from technology toward more meaningful patient engagement will enable policy planning for applications of technology that better meet patients’ needs. Second, a strong conceptual framework on guiding the meaningful use of technology in health care settings is essential for intelligent planning of virtual care policy. Conclusions: Policy planning for virtual care needs to shift toward a stronger focus on patient engagement to understand patients’ needs.

5 April 2021 in JMIR Formative Research
Verified
Journal Article
Open access
JSJames Shaw
James Shaw
LBLaPrincess C. Brewer
LaPrincess C. Brewer
TVTiffany Veinot
Tiffany Veinot
Background: The COVID-19 health crisis has disproportionately impacted populations who have been historically marginalized in health care and public health, including low-income and racial and ethnic minority groups. Members of marginalized communities experience undue barriers to accessing health care through virtual care technologies, which have become the primary mode of ambulatory health care delivery during the COVID-19 pandemic. Insights generated during the COVID-19 pandemic can inform strategies to promote health equity in virtual care now and in the future. Objective: The aim of this study is to generate insights arising from literature that was published in direct response to the widespread use of virtual care during the COVID-19 pandemic, and had a primary focus on providing recommendations for promoting health equity in the delivery of virtual care. Methods: We conducted a narrative review of literature on health equity and virtual care during the COVID-19 pandemic published in 2020, describing strategies that have been proposed in the literature at three levels: (1) policy and government, (2) organizations and health systems, and (3) communities and patients. Results: We highlight three strategies for promoting health equity through virtual care that have been underaddressed in this literature: (1) simplifying complex interfaces and workflows, (2) using supportive intermediaries, and (3) creating mechanisms through which marginalized community members can provide immediate input into the planning and delivery of virtual care. Conclusions: We conclude by outlining three areas of work that are required to ensure that virtual care is employed in ways that are equity enhancing in a post–COVID-19 reality.

7 July 2020 in Journal of Medical Internet Research
Verified
Journal Article
Open access
HAHassane Alami
Hassane Alami
PLPascale Lehoux
Pascale Lehoux
YAYannick Auclair
Yannick Auclair
MGMichèle de Guise
Michèle de Guise
MGMarie-Pierre Gagnon
Marie-Pierre Gagnon
JFJean-Paul Fortin
Jean-Paul Fortin
Artificial intelligence (AI) is seen as a strategic lever to improve access, quality, and efficiency of care and services and to build learning and value-based health systems. Many studies have examined the technical performance of AI within an experimental context. These studies provide limited insights into the issues that its use in a real-world context of care and services raises. To help decision makers address these issues in a systemic and holistic manner, this viewpoint paper relies on the health technology assessment core model to contrast the expectations of the health sector toward the use of AI with the risks that should be mitigated for its responsible deployment. The analysis adopts the perspective of payers (ie, health system organizations and agencies) because of their central role in regulating, financing, and reimbursing novel technologies. This paper suggests that AI-based systems should be seen as a health system transformation lever, rather than a discrete set of technological devices. Their use could bring significant changes and impacts at several levels: technological, clinical, human and cognitive (patient and clinician), professional and organizational, economic, legal, and ethical. The assessment of AI’s value proposition should thus go beyond technical performance and cost logic by performing a holistic analysis of its value in a real-world context of care and services. To guide AI development, generate knowledge, and draw lessons that can be translated into action, the right political, regulatory, organizational, clinical, and technological conditions for innovation should be created as a first step.